This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2013 Mar;54(3):441-2.

doi: 10.3109/10428194.2012.727420. Epub 2012 Sep 28.

"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia

Daphne R Friedman¹

Affiliations

PMID: 22950412
DOI: 10.3109/10428194.2012.727420

Comment

"Primum non nocere": the addition of granulocyte-macrophage colony stimulating factor to alemtuzumab in chronic lymphocytic leukemia

Daphne R Friedman. Leuk Lymphoma. 2013 Mar.

. 2013 Mar;54(3):441-2.

doi: 10.3109/10428194.2012.727420. Epub 2012 Sep 28.

Author

Daphne R Friedman¹

Affiliation

¹ Department of Medicine, Duke University Medical Center, Durham, NC 27710, USA. daphne.friedman@duke.edu

PMID: 22950412
DOI: 10.3109/10428194.2012.727420

No abstract available

PubMed Disclaimer

Comment on

Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
Zent CS, Wu W, Bowen DA, Hanson CA, Pettinger AM, Shanafelt TD, Kay NE, Leis JF, Call TG. Zent CS, et al. Leuk Lymphoma. 2013 Mar;54(3):476-82. doi: 10.3109/10428194.2012.717276. Epub 2012 Aug 22. Leuk Lymphoma. 2013. PMID: 22853816 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon